Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $202,817 - $256,457
5,901 Added 22.85%
31,725 $1.11 Million
Q1 2024

May 13, 2024

SELL
$34.2 - $47.13 $48,324 - $66,594
-1,413 Reduced 5.19%
25,824 $1.13 Million
Q4 2023

Feb 09, 2024

BUY
$24.59 - $35.83 $30,983 - $45,145
1,260 Added 4.85%
27,237 $969,000
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $78,317 - $110,655
3,717 Added 16.7%
25,977 $700,000
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $296,725 - $568,297
22,260 New
22,260 $523,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.33B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.